Free · no account · quoted from the filing

What changed in IQV's 10-Q

Source: 10-Q filed 2026-05-05 · compared against 10-Q 2025-10-28. Every passage below is quoted verbatim from the filing itself.

Segments

This filing

the Contract Sales & Medical Solutions segment, which had become more closely related operationally to the Technology & Analytics Solutions segment commercial offerings, was incorporated into the Technology & Analytics Solutions segment, which is renamed Commercial Solutions

Backlog / RPO

This filing

approximately $ 37.3 billion of revenues are expected to be recognized in the future from remaining performance obligations

Restructuring

This filing

restructuring costs 51 29

Interest expense

This filing

Interest expense 192 165

Tax

This filing

The Company's effective income tax rate was 18.0 % and 18.9 % in the first quarter of 2026 and 2025, respectively

Accounting standards

This filing

In December 2025, the FASB issued ASU 2025-10, Accounting for Government Grants Received by Business Entities

What it means — the analyst reading

The passages above are the company's own words. The plain-English reading of them — what changed, why it matters, and the direction of travel — is part of the Filing Change Monitor.

See the Filing Change Monitor →

Compared from narrative excerpts (outlook, risks, MD&A) of both filings — quotes are verbatim from the new filing. Not advice. Source: company SEC filings via stockportfolio.pro. Educational, not investment advice.